Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tahmina Rahman

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 15, 2024
Effects of dietary interventions for metabolic acidosis in chronic kidney disease: a systematic review and meta-analysisSepideh Mahboobi, Rebecca Mollard, Navdeep Tangri, et al.
Science (New York, N.Y.)|May 10, 2003
Crystal structure of the potassium channel KirBac1.1 in the closed stateAnling Kuo, Jacqueline M Gulbis, Jennifer F Antcliff, et al.
British Journal of Cancer|February 16, 2023
A Phase 1/2 study of the PD-L1 inhibitor, BGB-A333, alone and in combination with the PD-1 inhibitor, tislelizumab, in patients with advanced solid tumoursJayesh Desai, Peter Fong, Victor Moreno, et al.
Cancer Chemotherapy and Pharmacology|October 8, 2025
A phase I study of the OX40 agonist BGB-A445 with or without tislelizumab, an anti-PD-1 monoclonal antibody, in patients with advanced solid tumors: dose-escalation resultsJayesh Desai, Sanjeev Deva, Bo Gao, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 15, 2024
Effects of dietary interventions for metabolic acidosis in chronic kidney disease: a systematic review and meta-analysisSepideh Mahboobi, Rebecca Mollard, Navdeep Tangri, et al.
Science (New York, N.Y.)|May 10, 2003
Crystal structure of the potassium channel KirBac1.1 in the closed stateAnling Kuo, Jacqueline M Gulbis, Jennifer F Antcliff, et al.
British Journal of Cancer|February 16, 2023
A Phase 1/2 study of the PD-L1 inhibitor, BGB-A333, alone and in combination with the PD-1 inhibitor, tislelizumab, in patients with advanced solid tumoursJayesh Desai, Peter Fong, Victor Moreno, et al.
Cancer Chemotherapy and Pharmacology|October 8, 2025
A phase I study of the OX40 agonist BGB-A445 with or without tislelizumab, an anti-PD-1 monoclonal antibody, in patients with advanced solid tumors: dose-escalation resultsJayesh Desai, Sanjeev Deva, Bo Gao, et al.
Pageof 2